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Abstract
Background: The increasing availability of ‘omics’ databases provide important platforms for yeast engineering
strategies since they offer a lot of information on the physiology of the cells under diverse growth conditions,
including environmental stresses. Notably, only a few of these approaches have considered a performance under
recombinant protein production conditions. Recently, we have identified a beneficial effect of low oxygen
availability on the expression of a human Fab fragment in Pichia pastoris. Transcriptional analysis and data mining
allowed for the selection of potential targets for strain improvement. A first selection of these candidates has been
evaluated as recombinant protein secretion enhancers.
Results: Based on previous transcriptomics analyses, we selected 8 genes for co-expression in the P. pastoris strain
already secreting a recombinant Fab fragment. Notably, WSC4 (which is involved in trafficking through the ER) has been
identified as a novel potential target gene for strain improvement, with up to a 1.2-fold increase of product yield in
shake flask cultures. A further transcriptomics-based strategy to modify the yeast secretion system was focused on the
ergosterol pathway, an aerobic process strongly affected by oxygen depletion. By specifically partially inhibiting
ergosterol synthesis with the antifungal agent fluconazole (inhibiting Erg11p), we tried to mimic the hypoxic conditions,
in which the cellular ergosterol content was significantly decreased. This strategy led to an improved Fab yield (2-fold)
without impairing cellular growth. Since ergosterol shortage provokes alterations in the plasma membrane
composition, an important role of this cellular structure in protein secretion is suggested. This hypothesis was
additionally supported by the fact that the addition of non-ionic surfactants also enhanced Fab secretion.
Conclusions: The current study presents a systems biotechnology-based strategy for the engineering of the
industrially important yeast P. pastoris combining the use of host specific DNA microarray technologies and
physiological studies under well defined environmental conditions. Such studies allowed for the identification of
novel targets related with protein trafficking and ergosterol biosynthesis for improved recombinant protein
production. Nevertheless, further studies will be required to elucidate the precise mechanisms whereby membrane
biogenesis and composition impact on protein secretion in P. pastoris.
Background
The combination of the unexpectedly fast progress in
genome sequencing over the last decade and ‘omics’ ana-
lytical platforms have provided an invaluable source of
information on the physiology of yeasts, including a com-
prehensive overview on different cellular processes.
In several genome scale studies, Saccharomyces cerevisiae
has served as a useful model system to explain the com-
plexity of stress responses at the transcriptome level,
comprising important factors like temperature [1-3],
nitrogen starvation [4-6], osmolarity [7] and oxygen avail-
ability [8-11]. Nevertheless, only a small number of such
studies have investigated the impact of environmental
perturbations on already engineered yeast strains
(reviewed in [12]) - a scenario which is very likely to
resemble industrial processes. Considering the relevance
of yeast cell factories for commercial purposes and the
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tight interrelation between environmental stresses and
protein folding and secretion, such comprehensive stu-
dies are currently emerging as promising platforms
for systematic yeast strain engineering. For instance,
transcriptomic studies of recombinant S. cerevisiae
expressing a membrane protein [13] have lead to the
construction of improved production strains based on
the over expression of BMS1, involved in ribosome bio-
genesis, or deletion of several genes involved in transcrip-
tional regulation [14]. Sauer and co-workers [15]
reported the first series of genome scale cell physiology
studies of recombinant P. pastoris under stress condi-
tions. They compared the transcriptional profile of a
recombinant P. pastoris strain expressing human trypsi-
nogen to that of a non-expressing strain. Based on the
outcome of that work, Gasser et al. [16] selected a range
of significantly regulated genes and tested their S. cerevi-
siae homologues for co-expression in a recombinant
P. pastoris strain. Back then, the identification of six
novel (BMH2, BFR2, SSA4, SSE1, CUP5 and KIN2) and
five previously described secretion helpers (PDI1, ERO1,
HAC1, KAR2 and SSO2) already pointed to the success of
such a strain engineering strategy. The recent publication
of the P. pastoris genome sequence [17,18] permitted the
development of host-specific microarrays [19], and with
that also the independency of data interpretation on simi-
larities in S. cerevisiae. Dragosits and co-workers recently
reported the first P. pastoris specific ‘omics’ studies by
investigating the effect of temperature [20] and osmolar-
ity [21] on the transcriptome, proteome and metabolic
fluxes in a recombinant strain secreting an antibody Fab
fragment. Their work uncovered a decrease of the protein
folding stress at lower temperatures and, therefore, a pos-
sible correlation with the beneficial effect on protein
secretion. High osmolarity, on the other hand, did not
affect product yield, but trigged a physiological response
different from that described for S. cerevisiae. Data gener-
ated from these studies certainly form a useful knowledge
base for future systems metabolic engineering studies,
providing not only information on environmental stress
regulations under protein production conditions, but also
new insights into both host-specific and common limita-
tions in the secretion system when compared with other
expression platforms.
In an analogous study, we have recently reported the
transcriptome, proteome and fluoxome of a recombinant
P. pastoris strain expressing a Fab antibody fragment
under three different conditions of oxygen availability [22].
Paradoxically, although the need of sufficient oxygen for
oxidative protein folding and other processes would be
expected, we observed a beneficial effect of hypoxic condi-
tions on the specific productivity in chemostat cultivations
as well as in fed batch fermentations [23]. This striking
observation encouraged a more detailed analysis of ‘omics’
data aiming at the identification of potential new targets
for strain improvement. The outcome of this data mining
study and direct application of potential candidates in
screening experiments are presented in this work.
Results
Identification and cloning of potential target genes for
strain improvement
In order to select potential target genes for strain improve-
ment of the yeast P. pastoris, we compared the mRNA
profile of a recombinant strain to that of a non-expressing
control strain grown under different oxygenation condi-
tions [22]. This recombinant ‘reference strain’ secreted the
3H6 antibody Fab fragment as model recombinant protein
complex [24] and showed an increased secretion capacity
under hypoxic growth conditions [23]. Target genes for
improved Fab expression were mainly selected on the
basis of the magnitude of their regulation (relative ratios,
exceeding the fold change threshold of ± 1.5) in the
recombinant strain between hypoxic and normoxic condi-
tions, as well as on their potential relevance for recombi-
nant protein production. In addition, we included two
genes that were significantly up regulated in the recombi-
nant strain as compared to the non-producing control
strain under hypoxic conditions.
Overall, eight potentially interesting genes were consid-
ered for further analysis of the impact of their overex-
pression on recombinant protein secretion (see Table 1
for details).
Genes for co-overexpression were amplified from
P. pastoris genomic DNA and transformed into a P. pas-
toris X-33 strain expressing a 2F5 Fab antibody fragment
under control of the glycolytic GAP promoter. In this
study, the Fab 2F5 was used as a model protein for
screening because the ELISA assay used for quantifica-
tion of the Fab titer was originally optimized for this anti-
body and showed a higher reproducibility with Fab 2F5
than with its anti-idiotypic Fab 3H6 which was used in
the genome-scale study. Furthermore, such strategy
emerging from more than one model protein may also
indicate a broader applicability of the results.
Twelve individual clones of each co-overexpressing
strain were verified for integration of the gene of interest
by PCR. Some of the clones were lacking the insert,
thereby reducing the number of transformants for further
screening studies in 24-well culture plates to eight clones
per target gene construct.
The effect of co-expressed target genes on recombinant
Fab secretion in Pichia pastoris 24-well and shake flask
cultures
Series of eight verified clones overexpressing one of the tar-
get genes of interest were used in a first small scale screen-
ing in 24-well culture plates in duplicate experiments and
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Table 1 List of target genes for co-expression in P.pastoris Fab 2F5
Target gene ORF Description fold change adj p-value
ERO1 PIPA00063 Thiol oxidase required for oxidative protein folding in the endoplasmic reticulum 6.49 9.15E-07
NCE103 * PIPA03864 Carbonic anhydrase, involved in non-classical protein export pathway 3.36 4.08E-08
AQR1 * PIPA04502 Plasma membrane multidrug transporter of the major facilitator superfamily 17.03 2.25E-09
SLY41 PIPA02527 Protein involved in ER-to-Golgi transport 1.85 3.22E-04
TDH3 PIPA02510 Glyceraldehyde-3-phosphate dehydrogenase, involved in glycolysis and gluconeogenesis 4.38 5.44E-06
TEF4 PIPA00834, PIPA10574 Gamma subunit of translational elongation factor eEF1B, stimulates the binding of aminoacyl-tRNA to ribosomes 36.25 6.15E-10
TSA1 PIPA04168 Thioredoxin peroxidase, self-associates to form a high-molecular weight chaperone complex under oxidative stress 5.78 2.83E-06
WSC4 PIPA00592 ER membrane protein involved in translocation of soluble secretory proteins and insertion of membrane proteins into the ER membrane 2.57 8.82E-05
Target genes (systematic names and P. pastoris specific PIPA codes) for co-expression are listed together with their biological function. The fold change ratios and adjusted p-values derive from the pairwise
comparison of hypoxic and normoxic conditions. Target genes highlighted with (*) are also significantly (p-value < 0.05) upregulated in the Fab expressing strain compared to the control strain in hypoxic conditions.
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with random positions of the clones on the 24-well plate.
Product titers and biomass were measured by ELISA and
wet cell weight quantification, respectively. The average Fab
yields were normalized to those obtained from the empty
vector control strain, which showed very uniform expres-
sion levels also between clones (data not shown). The
results of these preliminary screening experiments are
shown in Figure 1. The overall picture of co-expression of
the selected target genes demonstrated a largely unchanged
protein secretion capacity, even indicating disadvantageous
rather than beneficial effects for several target genes.
Mutants with an essentially uniform negative impact on
Fab yield were those co-expressing TSA1, SLY41, AQR1
and, intriguingly, ERO1, which has been previously reported
to enhance protein secretion in S. cerevisiae [25] as well as
in P. pastoris [16]. Only one ERO1 mutant (ERO1 clone #9)
seemed to favour Fab secretion significantly in this small-
scale format. No such well-defined outcome was observed
with the mutants of NCE103, TEF4 and TDH3, since most
of them did not show any clear effect on Fab yield (neither
positive nor negative). Only clones co-expressing WSC4
demonstrated more promising results, with approximately
50% having a beneficial effect on Fab yield. Among these
tested transformants there was one WSC4 mutant (WSC4
clone #3) with a prominent increase in specific Fab expres-
sion (1.45 fold) relative to the control strain.
The Fab secretion capacity of a reduced set of ERO1
and WSC4 clones (# 2, 3, 9, 11 and # 3, 5, 9, 10, respec-
tively), was further verified by extending the number of
biological replica to three and performing cultivations
on a larger scale, that is, using baffled shake flasks. The
outcome of these experiments is shown in Figure 2. The
overall expression profile obtained and, in particular, the
recombinant Fab secretion increase of about 1.2-fold for
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Figure 1 24-well plate screening of co-expressing strains. Eight individual clones of each target gene and of a control strain containing the
empty vector were used for a small scale screening in 24-well plates. All cultures started with the same initial OD600 of 0.1 in BMD medium
containing 2% (w/v) glucose. After 24 hours, Fab titers and wet cell weight were calculated to determine the product yield (mgFab gWCW
-1) at a
given cultivation point (24 h). The yield ratios relative to the control strain (value = 1) are illustrated. Error bars indicate the standard error of the
means.
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both ERO1 clone #9 and WSC4 clone #3, confirmed the
results obtained in 24-well plates cultivations.
A plausible explanation for the observed clonal variation
would be that isolated transformants differed in the dosage
of the co-expressed ERO1 and WSC4 genes. In order to
test this hypothesis, the relative dosage and transcriptional
levels of ERO1 and WSC4 were determined by qPCR for
two independent clones of each construct (ERO1 clones
#9 and 11, and WSC4 clones #3 and 10), one giving a
clear increased Fab yield and the other no significant (or
negative) effect on product yield, compared with the refer-
ence strain. Results revealed that there was no difference
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
2F5 #2 #3 #9 #11
re
la
tiv
eF
ab
p
ro
du
ct
yi
el
ds
CoͲexpression ofERO1inshake flasks
0.6
0.7
0.8
0.9
1
1.1
1.2
1.3
1.4
2F5 #3 #5 #9 #10
re
la
tiv
eF
ab
pr
od
uc
ty
ie
ld
s
CoͲexpression ofWSC4inshake flasksA
B
Figure 2 Shake flask screening of clones co-expressing ERO1 and WSC4. Relative product yields of ERO1 (A) and WSC4 (B) co-expressing P.
pastoris clones (4 individual clones from each target gene) secreting the recombinant Fab antibody. The data were normalized to the control
culture values, and error bars indicate the standard error of the means.
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in the co-expressed gene dosage. Moreover, differences in
terms of mRNA levels for ERO1 andWSC4 genes amongst
the corresponding selected clones were not statistically
significant. Also, Fab LC and HC mRNA levels amongst
these clones, as well as with respect to the reference strain,
were similar (data not shown). This suggested that other
parameters may be involved in the clonal variation
observed in terms of Fab secretion yield.
Identification and manipulation of potential target
metabolic pathways for strain engineering
In addition to the identification of novel target genes
involved in cellular processes directly connected to protein
secretion, transcriptomic analyses allowed the identifica-
tion of other metabolic pathways with notable alterations
in hypoxic conditions and, therefore, potentially interfer-
ing or related to protein secretion. In particular, we
focused on the ergosterol and sphingolipid synthesis path-
ways, which are aerobic processes requiring molecular
oxygen and, therefore, were particularly affected under
hypoxic conditions. For both, Fab-producing and empty
vector control strains, the regulation pattern was very uni-
form, with a considerable induction of a number of genes
catalyzing oxygen dependent reactions. A specific observa-
tion that prompted us to investigate in the first place one
these pathways in more detail was the significantly stron-
ger induction of the ergosterol biosynthesis gene ERG25 in
the recombinant strain when compared to the non-expres-
sing strain. A scheme of the ergosterol synthesis pathway
is illustrated in Figure 3. It is well known that manipulat-
ing the ergosterol pathway can be delicate, especially in
terms of deletion mutants, since many of the ERG genes
are essential. The first strategy to circumvent this problem
was the treatment with the antifungal agent fluconazole, a
specific inhibitor of lanosterol C-14alpha demethylase
encoded by ERG11, as indicated in Figure 3.
A second approach was the addition of detergents to the
culture medium. These compounds, in particular Tween
80, are typically supplied to anaerobic S. cerevisiae cultiva-
tion media in order to sustain growth. Furthermore, such
non-ionic surfactants are also known to alter the mem-
brane fluidity of the cells [26,27]. Since ergosterol is an
important component of the yeast membrane and altera-
tions in sterol distribution (i.e. by inhibition of ergosterol
synthesis) are known to impact membrane permeability
[28], application of detergents like Tween or Triton might
exert a similar effect.
Effect of partial inhibition of the ergosterol pathway on
heterologous protein secretion - treatment with
Fluconazole
The P. pastoris 2F5 Fab expressing strain was cultivated
in 24-well plates in the presence of 0~100 μg ml-1 fluco-
nazole. After plotting the growth curves (Figure 4A), we
determined a range between 0.2 and 1 μg ml-1 to be opti-
mal for the fluconazole screening experiments. 1 μg ml-1
turned out to be the maximum concentration without
showing any interference with cellular growth. The
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Figure 3 Schematic view of the ergosterol pathway and fluconazole inhibition. Outline of the post-squalene ergosterol biosynthetic
pathway illustrating the step inhibited by fluconazole. Dashed arrows indicate no specification of intermediates, and red arrows highlight the
genes that are upregulated in the Fab strain in hypoxic conditions.
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screening in baffled shake flasks included biological tri-
plicates for concentrations of 0.2, 0.4, 0.8 and 1.0 μg ml-1,
as well as the negative control without fluconazole treat-
ment. As shown in Figure 4B, fluconazole in concentra-
tions up to 0.6 μg ml-1 had a beneficial effect on Fab
secretion (about 1.4-fold increase), whereas higher con-
centrations lead to a negative effect.
Sterol analyses after Fluconazole treatment
Since fluconazole inhibits the lanosterol C-14a demethy-
lase step in the ergosterol biosynthesis pathway, the treat-
ment with this antifungal drug is expected to decrease
the ergosterol content. In order to prove this hypothesis,
sterol composition from cells grown in the presence of
0.6 μg ml-1 fluconazole, that is, the concentration in
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Figure 4 Fluconazole screening. A: Determination of the fluconazole working concentrations. Growth curves of the recombinant P. pastoris
strain X-33 pGAPZaA Fab2F5 grown in BMD medium and in the presence of 0 - 2 μg ml-1 fluconazole. B: Fluconazole screening in shake flask
cultures. Fab productivities in different concentrations of fluconazole (0.2 - 1.0 μg ml-1) were normalized to the values obtained from non-treated
cells. The relative Fab productivities for each concentration are demonstrated, error bars indicate the standard error of the means.
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which a higher Fab secretion was achieved, was analyzed
and compared to the sterol content of non-treated cells
(Table 2). Indeed, results summarized in Table 2 show a
different sterol composition when comparing flucona-
zole-treated vs. untreated cells, including a clear decrease
in the ergosterol content. Notably, the analyses also
revealed the appearance of two novel sterol compounds
in the fluconazole-treated cells, which could not be iden-
tified by GC-MS (see Supplementary file 1). These com-
pounds, which showed a higher retention time than
ergosterol in GC analyses, could be intermediates of the
ergosterol biosynthesis pathway, e.g. lanosterol. In fact,
previous studies [29] have shown that inhibition by of
sterol-14a-demethylase by fluconazole (and other azole
drugs) results in depletion of ergosterol and accumula-
tion of the substrate, lanosterol, as well as 14a-methy-
lated sterols.
Effect of potential alterations in membrane fluidity by
treatment with non-ionic surfactants
In preliminary experiments, we identified Tween 80 as
enhancer for protein secretion, increasing the product
yield 3-fold in small scale 24-well plate cultivations
(data not shown). As a consequence, a more detailed
analysis of the effect of Tween 80 and two closely
related non-ionic surfactants - Tween 20 and Triton
X-100 - on recombinant protein secretion was per-
formed in shake flasks cultures of the P. pastoris X-33
2F5 Fab expressing strain. All three detergents were
added at a concentration of 42 mg l-1, which is typically
applied to anaerobic S. cerevisiae cultivations (see for
example [30]). Tween 80 addition to shake flask cultures
increased Fab secretion 1.65 fold. A stimulating effect
could also be seen with Tween 20 (1.3 fold) and Triton
X-100 (1.4 fold) (Figure 5).
Discussion
Systems biotechnology offers new strategies for yeast
strain engineering [31]. In this study, a DNA microarray
based data mining from experiments that showed an
increased productivity of a complex foreign protein in P.
pastoris has led to the identification of novel target genes
or pathways for the improvement of heterologous protein
production.
Engineering of the protein folding and quality control
machinery is a very common and successful strategy to
increase the secretory capacity of yeasts. For instance,
overexpression of the unfolded protein response (UPR)
proteins Pdi1p and Hac1p, the ubiquitin Ubi4p, and the
chaperones BiP/Kar2p, Jem1p and Cne1p have been
extensively shown to improve protein secretion (all
reviewed in [12]).
The protein disulfide isomerase (Pdi) recycling assistant
Ero1p, an ER membrane-resident protein and key compo-
nent of the oxidative folding machinery, has also been
reported as helper factor to increase the yields of human
serum albumin in K. lactis [32] and of the human Fab 2F5
antibody fragment in P. pastoris [16]. It is particularly for
this reason that we expected to observe a similar effect in
this study. At this point, however, it has to be stated that
although the model protein in this study was identical to
that used by Gasser and co-workers [16], the experimental
design differed in three pivotal points: firstly, the strain
was a protease deficient SMD1168 (pep4 mutant); sec-
ondly, the expression vector carrying the gene ERO1 was
based on histidine selection, 3 times bigger in size and
integrated in a different locus (HIS4); and thirdly, the
ERO1 gene was derived from S. cerevisiae genomic DNA,
while in this study the host specific P. pastoris ERO1 gene
was amplified and over expressed. Despite these dissimila-
rities, the magnitude of the beneficial effect shown
by ERO1 clone#9 was overlapping with that reported in
Gasser et al. [16]. In relation to the clonal variation
observed amongst ERO1 clones (as well as for the rest of
co-expressed genes), it has recently been observed that the
gene dosage of PDI determines whether its co-expression
has a beneficial or detrimental impact on foreign protein
secretion [33]. Besides, clonal variation could be also par-
tially due to genetic differences (mutations) generated dur-
ing the transformation event, as previously suggested [34].
Unlike ERO1, WSC4 has not been described as a helper
factor for increased protein secretion so far. Wsc4p is a
component of the ER and plays a role in the translocation
of soluble proteins as well as the insertion of proteins tar-
geted to the ER membrane. A contribution of the WSC
family to enhanced environmental stress resistance has
also been suggested [35,36]. Interestingly, WSC4 is the clo-
sest of the four S. cerevisiae homologues to the TSR1 gene
of Yarrowia lipolytica, whose gene product assists in the
Table 2 Composition of major sterols in both untreated
and fluconazole-treated P. pastori s cells
Sterol μg Sterol/mg DCW
Control culture Fluconazole-treated culture
Unknown 1 0 0.5
Unknown 2 0 0.47
Squalen 0 0
Zymosterol 0.17 0
Ergosterol 9.81 6.77
Fecosterol 0.21 0
Episterol 0.23 0
Total sterols 10.42 7.74
Amounts of sterol (μgsterol mgDWC
-1) were determined from P. pastoris X-33
pGAPZaA Fab2F5 cells treated with 0.6 μg ml-1 fluconazole and compared
with untreatred cells. Unknown 1 and 2 refer to non-identified compounds
detected in GC analyses of the sterol fraction of fluconazole-treated P. pastoris
cells (see Additional file 1).
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signal recognition particle (SRP) - dependent translocation
of proteins through the ER and also interacts with the
UPR-regulator BiP [37]. The potential link to the UPR and
its role in protein sorting through the ER membrane may
explain the beneficial effect of WSC4 overexpression on
Fab secretion. Consistent with these results is the finding
that a S. cerevisiae null mutant of WSC4 (the gene is
termed YCH8) accumulated soluble protein precursors,
indicating defects in protein trafficking [38]. A further link
between the WSC family and the secretory pathway
includes the activity of Wsc1p in secretory defective cells,
where it is required for the repression of genes that make
up the protein-synthetic machinery [39]. Although this
observation would contradict the herein proposed role of
WSC4 on protein secretion (inferred from sequence simi-
larities), it has to be stated that that the functions of the
Wsc proteins overlap only partially. In fact, an implication
in the signalling pathway that mediates the response to an
interruption of the secretory pathway has been reported
also for Wsc2p and Wsc3p, but not for Wsc4p [40]. We
therefore believe that WSC4 deserves closer attention as a
potential target of the secretory system for engineering
host cells.
During the identification of potential target genes signifi-
cant changes were observed in the oxygen-dependent
ergosterol and sphingolipid biosynthesis pathways. In
addition to the strong transcriptional induction of these
pathways in both strains under hypoxic conditions and, in
particular, of oxygen consuming reactions therein, ERG25
was also significantly stronger expressed in the Fab produ-
cing strain. Considering that this stronger induction
resulted not only from oxygen depletion but also from the
additional charge of recombinant protein expression, we
suggested a potential role of ergosterol or an intermediate
during the protein secretion process. In order to investi-
gate the capacity of this important component of the yeast
membrane to influence protein secretion, its biosynthesis
was perturbed by applying the antifungal agent flucona-
zole, which specifically inhibits the activity of Erg11p in
the late steps of the ergosterol pathway (see Figure 3).
Interestingly, the cumulative silencing of its synthesis by
applying increasing amounts of fluconazole favoured pro-
tein secretion to its maximum at a concentration of 0.6 μg
ml-1, while higher concentrations inhibited growth and
therefore suggest a complete breakdown of ergosterol
synthesis with fatal consequences for the cell. This partial
silencing of the ergosterol synthesis by inhibiting Erg11p
may resemble the ergosterol deprivation in hypoxic condi-
tions. In fact, the ergosterol content was significantly
decreased in fluconazole-treated cells, as shown in Table
2, thereby effectively mimicking the impact of hypoxia on
the macromolecular composition of P. pastoris [41]. We
therefore suggested that the strong transcriptional induc-
tion of the pathway under oxygen scarcity might only
reflect compensation for the intermediate substrate deficit
provoked by reduced oxygen availability. In which way
ergosterol depletion affects protein secretion has to be elu-
cidated, but combining published data with the outcome
of this work points to the plasma membrane as key player.
Ergosterol and sphingolipids are highly abundant in the
yeast plasma membrane and to a lesser extent in other cel-
lular membranes, where they assemble to form so-called
lipid rafts [42]. These microdomains are composed of
tightly packed sphingolipid acyl chains, attributing them
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Figure 5 Effect of Tweens and Triton X-100 on Fab yield in shake flasks. The effect of the non-ionic surfactants Tween 20 (T-20), Tween 80
(T-80) and Triton X-100 (TX-100) on the Fab productivity in P. pastoris X-33 pGAPZaA Fab2F5 is demonstrated. The mean ratios of treated
samples normalized to the untreated control samples are illustrated, and error bars indicate standard errors of the means.
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detergent resistance (i.e. to non-ionic surfactants like
Triton X-100). An important feature of such lipid rafts is
their contribution to protein sorting, since the targeting of
membrane protein cargo to the cell surface requires early
raft association already in the ER [43]. As a consequence,
defective synthesis of sphingolipids and ergosterol has
been shown to impair the trafficking and sorting of a raft-
associated chimeric protein to the cell surface [43], and
also resulted in missorting of the plasma membrane
ATPase Pma1p to the vacuole for degradation [44,45].
Bagnat and co-workers have shown that sphingolipids and
ergosterol were required for incorporation of the cell wall
protein Gas1p (a GPI-anchored a-1, 3-glucanosyltransgly-
cosylase) to detergent resistant membranes (DRM), but
not for vacuolar or secreted proteins [46]. Consequently,
ergosterol depletion may lead to reduced Gas1p in vivo
incorporation to the cell wall and, therefore, increased cell
wall porosity due to reduced ß-glucan crosslinking; this
effect might facilitate the passage of heterologous proteins
through the cell wall in a similar way as observed in GAS1
knockout strains [47]. We assume that the defective trans-
port of proteins destined to be incorporated to the plasma
membrane might unbalance membrane fluidity by impair-
ing the formation of lipid rafts. The consequences may
include a less stringent control of the exchange of macro-
molecules between the cell and its proximate environ-
ment, possibly including secreted proteins whose
translocation through the cell is not affected by ergosterol
and sphingolipid depletion. It is also likely that membrane
proteins that are not incorporated into the DRM, which
usually takes place at the ER or Golgi level, are not incor-
porated into transport vesicles either, thus alleviating such
transport compartments from cargo and facilitating the
additional uptake and translocation of soluble proteins.
These results, although preliminary, support evidence for
a complex interaction between cellular membranes and
protein secretion, implicating the plasma membrane as
hitherto only marginally regarded, but promising target for
strain engineering.
In addition, non-ionic surfactants including Tween80,
Tween 20 and Triton X-100 were identified as potential
enhancers of Fab secretion in P. pastoris with the highest
(2 fold) increase in Fab productivity of cells grown in the
presence of Tween 80 and a less pronounced increase
after addition of Tween 20 or Triton X-100. This is not
the first study that reports evidence for a stimulatory effect
of Tweens or similar non-ionic surfactants on protein
secretion. In bacteria, Tween 80-stimulated glycosyltrans-
ferase production correlated with alterations in membrane
fluidity [26,27]. The authors of these studies suggested
that an increase in fluidity of the membrane lipids might
facilitate the release of intracellular accumulated protein,
thereby enhancing its rate of secretion. The beneficial
effect of surfactants, including Tween, appeared to be
valid also in other organisms, including cellulase secreting
Trichoderma reesei [48], recombinant Schizosaccharo-
myces pombe [49] and recently also in recombinant P. pas-
toris [50,51]. Apart from the more apparent explanation of
a “leakier” plasma membrane that facilitates translocation
of soluble proteins, speculations about the mechanisms
underlying this effect also included fluctuations in the
electrochemical gradient and enhanced membrane fusions
of transport vesicles. This latter finding could also explain
the observed increase in secreted Fab after the decrease of
ergosterol biosynthesis by fluconazole treatment. A desta-
bilization of the membranes by sterol deficiency could
favour such membrane fusions and increase the volume of
transport vesicles and consequently also the size of the
cargo to be delivered to the surface.
In good accordance with these assumptions, in S. cerevi-
siae cultures grown under comparable conditions and
expressing the same model protein, no hypoxic effect - i.e.
favoured protein secretion by oxygen depletion - has been
observed, probably because ergosterol synthesis did not
seem to be affected on the transcriptional level either [52].
Our findings give therefore strong evidence for cellular
membranes or membrane related genes and pathways as
promising strain engineering targets.
Conclusions
The current study illustrates how the combination of com-
prehensive genome-scale transcriptomics analyses using
host specific DNA microarray technologies and physiolo-
gical studies under defined conditions of different oxygen
availability allowed for the identification of novel potential
target genes and pathways for the engineering of the
industrially important yeast P. pastoris. There is evidence
that the complexity of many interacting elements (or cel-
lular processes) makes metabolic engineering for improved
protein secretion a challenging task. Nevertheless, previous
reports clearly point out that the engineering of the pro-
tein folding and quality control system in the ER is a feasi-
ble strategy, even if it is only based on the modification of
a single gene. Protein folding and ER quality control are
certainly two of the best explored mechanisms in engi-
neering studies and comprise a great number of target
genes, essentially because of their apparent interrelation
with protein production.
Even more promising results pointed to a strong inter-
relation of the ergosterol pathway and, thus, the plasma
membrane, with the yeast secretion system, making it a
novel target for systematic strain engineering studies. In
hypoxic conditions, the ergosterol biosynthetic genes
were strongly induced, but the cellular ergosterol con-
tent was decreased. Mimicking these conditions by spe-
cifically blocking ergosterol synthesis with the antifungal
agent fluconazole indeed resulted in an increased Fab
secretion. Furthermore, plasma membranes also undergo
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perturbations upon treatment with non-ionic surfactants
like Tweens. The fact that treatment of P. pastoris with
such detergents yielded in a higher amount of extracel-
lular Fab provides further evidence for a close interrela-
tion between protein secretion and plasma membrane
alterations.
Altogether, it turned out that such a systematic
approach for finding novel targets, albeit not being a
high-throughput strategy, serves as valuable tool for
strain engineering. Such a strategy would be even more
powerful when applying similar cultivation conditions to
other microbial host systems for a comparative analysis,
with the aim to find host specific as well as common lim-
itations in protein secretion. Moreover, we envisage that
the integration of transcriptomics data into genome-scale
metabolic models (made recently available for P. pastoris,
[53]) should facilitate the systematic extraction of infor-
mation useful for subsequent rational strain engineering
strategies.
Methods
Strains and strain engineering
The starting strain used in this study was a Pichia pas-
toris X-33 pGAPZaA Fab2F5 strain. A detailed descrip-
tion of the construction of the vector containing the
recombinant protein as well as transformation condi-
tions are found in [54]. In brief, the expression cassettes
for the light and heavy chain of the human Fab 2F5
antibody fragment were separately placed under the
control of the P. pastoris GAP (glyceraldehyde-3-phos-
phate dehydrogenase) promoter and combined on one
plasmid. This vector, conferring resistance to Zeocin™,
was integrated into the genome of P. pastoris host strain
X-33 (wild-type phenotype).
Eight host specific gene targets have been selected for co-
overexpression studies in the Fab 2F5 expressing X-33 P.
pastoris strain. The selection of these genes was based on a
previous genome-wide study in P. pastoris [22]. The list of
genes and the corresponding primers used for the amplifi-
cation from genomic X-33 DNA are given in Table 3. The
primers were flanked with the sequences of the restriction
sites SfiI and SbfI for cloning into the vector pPUZZLE
[55], which confers resistance to kanamycin in bacteria and
geneticin G418 in yeast. After propagation of the vectors
carrying the gene of interest in E. coli DH5a, plasmids
were purified and sequenced with the primers pGAP
(5’GATTATTGGAAACCACCAGAATCG) and pPUZZLE
(5’GGCGTGAATGTAAGCGTGAC). The verified plasmid
constructs were then linearized with AscI (FastDigest, Fer-
mentas) for integration into the transcription termination
locus of AOX1 (AOX1 TT), and transformed into X33
pGAPZaA Fab 2F5 competent cells. For the reference
strain, the empty pPUZZLE vector was used.
Transformation and direct selection of yeast
transformants on G418
Pichia pastoris competent cells were prepared according
to the condensed protocol described in [56]. Prior to
transformation, 40 μl competent cells were mixed with
100 ng of the linearized and purified plasmid DNA and
chilled on ice for 5 minutes. Electroporation was carried
out on a BioRad Gene Pulser (BioRad), with the electro-
poration parameters set to 1500 V, 25 μF and 400 Ω.
Shortly after transformation, cells were resuspended in
Table 3 List of primers used for amplification of genes for co-expression in P.pastoris Fab 2F5
Target gene Primer name Primer sequence
ERO1 ERO1_fwd 5’ AACTGCCTGCAGGACC_ATGAGGATAGTAAGGAGCGTAGCTAT
ERO1_rev 5’AATCGGGCCGAGGCGGCC_TTACAAGTCTACTCTATATGTGGTATCT
NCE103 NCE103_fwd 5’ AAGCGCCTGCAGGACC_ATGGGTGGTTTATCATTTGA
NCE103_rev 5’ AATCGGGCCGAGGCGGCC_TTAATGTCCACCGGCTTCAGTATCA
AQR1 QDR2_fwd 5’ AACTGCCTGCAGGACC_ATGACAAATGAAAAATTGGATTTG
QDR2_rev 5’AATCGGGCCGAGGCGGCC_CTACAGTTTGTATTTTGTTCCCCTCCTA
SLY41 SLY41_fwd 5’ AACTGCCTGCAGGACC_ATGATCATTACGCAGAATCT
SLY41_rev 5’ AATCGGGCCGAGGCGGCC_CTAGTTTTTGACTGCACCCCATTT
TDH3 TDH3_fwd 5’ AAGCGCCTGCAGGACC_ATGGCTATCACTGTCGGTAT
TDH3_rev 5’ AATCGGGCCGAGGCGGCC_TTAAGCCTTAGCAACGTGTT
TEF4 TEF4_fwd 5’ AACTGCCTGCAGGACC_ATGTCGCAAGGAACAATTTAC
TEF4_rev 5’ AATCGGGCCGAGGCGGCC_TTAATTACTCTTGGGTGGAACAT
TSA1 TSA1_fwd 5’ AACTGCCTGCAGGACC_ATGTTTGGACTAAATCACGAGATA
TSA1_rev 5’ AATCGGGCCGAGGCGGCC_CTATTTGGACTTGGAAAAGAA
WSC4 WSC4_fwd 5’ AACTGCCTGCAGGACC_ATGTTGTTGAAGTTGATTTGGGTATTT
WSC4_rev 5’ AATCGGGCCGAGGCGGCC_TTAGGCATTATTTCCTGGGGTCTCT
List of primer sequences used for amplification of the target genes from genomic P. pastoris DNA http://www.pichiagenome.org. The sequences of the restriction
sites SfiI (GGCC NNNN^NGGCC) and SbfI (CCTGCA^GG) are underlined.
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500 μl 1 M sorbitol and 500 μl YPD and incubated at
30°C for at least 3 h or overnight in 15 ml Falcon tubes.
About 25 - 300 μl of this cell suspension was spread on
YPD agar plates containing 500 μg ml-1 G418 (Invivo-
gen). After 2 - 3 days only the big (Ø > 2 mm) colonies
were picked, and its genomic DNA extracted (Wizard®
Genomic DNA Purification Kit, Promega) and checked
for correct integration by PCR screening with the pGAP
and pPUZZLE primers (vector specific).
Cultivation conditions and screening for Fab expression
For the screening in 24-well cell culture plates (Whatman),
2 ml of Buffered Minimal Glycerol (BMG) medium (100
mM potassium phosphate (pH 6.0), 1.34% (w/v) yeast
nitrogen base (without amino acids), 4 × 10-5 % (w/v) bio-
tin, 1% (v/v) glycerol were inoculated with a fresh colony
and incubated over night at 25°C and 250 rpm in an orbi-
tal shaker (Infors). Cultures were sealed with gas perme-
able, sterile BREATHseal™ (Greiner) membranes for
maintaining optimal oxygen supply in the cultures. After
14-16 hours, optical density was measured at 600 nm
(OD600), and cells were diluted into a fresh Buffered Mini-
mal Dextrose medium (containing 2% (v/v) dextrose as
carbon source) to an initial OD600 of 0.1. After 24 hours,
1 ml cells were harvested and centrifuged at 13, 000 rpm
for 1 minute. The supernatant was stored at -20°C for
ELISA analysis, and the pellet was used for the determina-
tion of the wet cell weight (WCW). For each strain con-
struct, relative Fab yield was calculated from technical
triplicates on biological duplicates.
For the shake flask cultures, 5 ml of BMG medium in
50 ml-Falcon tubes were inoculated to an initial OD600 of
0.1 from an overnight culture in YPD and incubated at
25°C and 180 rpm in a Multitron II orbital shaker (Infors).
After approximately 16 hours, these seed cultures were
used to inoculate 250 ml-volume baffled Erlenmeyer con-
taining 25 ml of a fresh BMD medium at an initial OD600
of 0.1). Cultures were incubated for 24 hours under the
same temperature and agitation conditions. For the deter-
mination of the dry cell weight (DCW), 2 × 10 ml of the
cultures were washed twice with sterile ddH2O and fil-
tered through pre-dried and pre-weighed glass fibre filters
(0.7 μm pore size, Whatman). Filters containing the yeast
biomass were then dried at 105°C for 24 h, cooled down
in a desiccator and weighed. The Fab yield from shake
flask experiments (including Tween and fluconazole treat-
ments), was determined from three biological replicates
analysed in technical triplicates.
Treatment with Tween 80, and other non-ionic
surfactants
For the P. pastoris cultures treated with Tween 80,
Tween 20 and Triton X-100 these components were dis-
solved (v/v) in water and added to the culture medium
BMD at final concentrations of 42 mg l-1. Additionally,
cells were cultured separately without any treatment as
negative controls.
Fluconazole treatment
Fluconazole is an antifungal agent and interferes with
fungal ergosterol synthesis. It specifically inhibits lanos-
terol C-14a demethylase, encoded by the yeast ERG11
gene. A fluconazole stock solution (100 μg ml-1 in H2O)
was added to the culture medium BMD at final concen-
trations ranging between 0 and 1.0 μg ml-1.
Analysis of total sterols
Total sterol content was quantified as previously described
[57]. Briefly, lyophilized cells (0.1 g) were treated for
20 min at 100°C in 0.5 N HCl and allowed to cool to
room temperature. After addition of 3 g of KOH and
12.5 ml of methanol with pyrogallol (0.25 g l-1) and stig-
masterol as internal standard (8 mg l-1), the mixture was
saponified by incubation for 1.75 h at 70°C in a water
bath. Sterols were extracted two times with n-hexan
(20 ml), dried by rotation evaporator, resuspended in 2 ml
chloroform and derivatized with MSTFA (N-Methyl-N-
trimethylsilyltrifluor-acetate). Sterols were separated on an
Agilent 6890N gas chromatograph coupled with an Agi-
lent 5975B VL mass spectrometer (GC-MS) on a capillary
column (30 m by 0.25 mm and 0.25 μm film thickness;
Agilent Technologies, HP-5MS, 19091S-433). The tem-
perature was initially 150°C for 0.5 min; it was then
increased at 40°C min-1 to a temperature of 280°C, further
increased at 2°C min-1 to a temperature of 310°C and
finally to a temperature of 350°C which was held for
2 min. The linear velocity was 19 cm s-1, helium was used
as the carrier gas, and injections were run in the splitless
mode. The injection volume was 1 μl. It was detected each
mass between 29 to 500 amu all the time. The area of
each peak was calculated and related to 1 g of cell dry
weight. Each sample was measured in triplicate. Sterols
were quantified via the internal standard stigmasterol and
the external standards ergosterol, cholesterol and squa-
lene. Ergosterol was used for the quantification of all
“ergosta"-Intermediates as well as for substances which
could not be identified. Cholesterol was used for the quan-
tification of all “cholesta"-intermediates and squalene was
used for the quantification of squalene.
Quantification of the Fab 2F5 antibody by sandwich
ELISA
96 well plates (Nunc) were pre-coated with a Fab-specific
anti-human IgG (Sigma) 1:1000 diluted in PBS, and incu-
bated over night at room temperature. After washing the
plates, samples and the Fab standard (Bethyl Inc.) were
diluted in PBS containing 10% (w/v) bovine serum albu-
min and 0.1% (v/v) Tween 80 and applied in duplicates
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(standard) or triplicates (samples). Plates were incubated
for 2 hours, washed, and incubated for another hour with
the secondary alkaline phosphatase-conjugated anti-kappa
light chain antibody (Sigma). After a thorough washing
step, plates were treated with the phosphatase substrate
pNPP (Sigma) and measured at 405 nm (reference filter
620 nm) on a micro plate reader (Fisher Scientific). Data
analysis was performed by using a standard curve (hFab
standard) and a polynomial function.
Genomic DNA and total RNA preparation
Selected clones overexpressing the genes of Ero1 and
Wsc4, as well as the control strain (X-33 producing the
Fab 2F5) were cultured in BMD (2% Dextrose) media to
an initial OD600 of 0.1 for 24 h at 25°C and 180 rpm. To
maintain cells for further extractions, 9 ml of culture were
mixed with 5 ml of freshly made chilled 5% (v/v) phenol
(Sigma) solution in absolute ethanol, centrifuged at 4°C
and 12, 000 rpm for 5 min; harvested cells were stored at
-80°C until extraction.
RNA extractions were performed with RNeasy Mini Kit
(Quiagen) following manufacturer’s protocol of enzymatic
extraction using lyticase (Sigma). RNA samples were
quantified and analysed for purity using Experion RNA
StdSens Analysis Kit (Bio-Rad) with a RQI between 8.8
and 9.9.
Genomic DNA extraction of the cells was also per-
formed using Wizard® SV Genomic DNA (Promega) and
quantified with Nanodrop™3300 (Thermo Scientific).
Samples were diluted in DEPC water (Ambion) to a final
concentration of 1 ng μl-1 to be further used in qRT-PCR.
cDNA generation and primer design
For the generation of cDNA, RNA extractions were sub-
jected to a DNAse I Amplification Grade (Invitrogen)
treatment prior to reverse transcription with SuperScript®-
VILO cDNA Synthesis Kit (Invitrogen). All steps were per-
formed following the manufacturer’s protocol, starting
from 1 μg RNA. After cDNA generation, samples were
purified (Clean-Up Wizard® SV Gel and PCR Clean up
system, Promega) and quantified with Nanodrop™3300
(Thermo Scientific). Samples were diluted with DEPC
water (Ambion) to a final concentration of 1 ng μl-1 and
2 μl were used for qRT-PCR analysis. Oligonucleotides
(purchased from biomers.net) were designed with the
Clone Manager Professional, version 9 software http://
www.scied.com and Primer3 http://frodo.wi.mit.edu/pri-
mer3/, considering an amplicon size of 100 - 200 bp and a
Tm of approximately 60°C (Table 4).
Primer validation and amplicon purification for standard
curve
To guarantee that each primer pair yields a single PCR
product of the predicted size, we performed a conventional
PCR and confirmed the absence of any primer dimers or
unspecific products on a 2% (w/v) agarose gel. To addition-
ally check the specificity of the assay, a melt-curve analysis
was performed at the end of each PCR assay. An optimized
reaction should have a single peak in the melt-curve, corre-
sponding to the single band on the agarose gel. The speci-
fic PCR products were purified (Wizard® SV Gel and PCR
Clean-Up System, Promega) and quantified on a Nano-
drop™3300 (Thermo Scientific). From the concentration
and the size of the amplicon, the copy number per μl was
determined according to Whelan [58] and decimal dilu-
tions representing 107 - 103 copies of target DNA were
used for standard curve generation.
qRT-PCR assay
Quantitative real-time PCR was carried out in 20 μl reac-
tions using semi-skirted iQ 96-well PCR plates and
iQ™SYBR® Green supermix (Bio-Rad). Samples were
measured in triplicates and standards were measured in
duplicates on the iCycler Thermal Cycler (Bio-Rad). A
non-template control was run in every experiment for
each of the primer pairs to avoid detection of unspecific
priming. The reactions were incubated at 95°C for 10 min
to activate the Taq polymerase, and then subjected to a
three-step cycling protocol including melting (95°C,
15 sec), annealing (58°C, 15 sec) and extension (72°C,
30 sec) for a total of 40 cycles. Each extension was fol-
lowed by data collection at 72°C. After a final extension of
5 min at 72°C, a melt-curve profile was generated by data
collection during 81 cycles starting at 55°C to 95°C, with
0.5°C increments/cycle (1-sec intervals).
Data analysis
The relative gene expression was calculated for each
sample with three measurements giving a maximum
standard deviation of 1%. Since amplification efficiencies
Table 4 List of primers used for quantification of gene
dosage and transcriptional levels by qRT-PCR
Target
gene
Primer name Primer sequence
ERO1 5’ERO1_qPCR_vie 5’ GTTGGAAAAGCCGCATATAAACAAAACA
3’ERO1_qPCR_vie 5’ CAGCTTGGGCAAAGTCCTGTAAGAGTTC
WSC4 5’WSC4_qPCR 5’ CAGCACCATCCATATCAACC
3’WSC4_qPCR 5’ GTTTGCGGATCTTGAGCTAC
ACT1 5’ACT1_qPCR_vie 5’ CCTGAGGCTTTGTTCCACCCATCT
3’ACT1_qPCR_vie 5’
GGAACATAGTAGTACCACCGGACATAACGA
2F5_HC 5’2F5_HC_qPCR 5’ CTCTCACGCTGACCTGTTCC
3’2F5_HC_qPCR 5’ GATTGCAAGCCACTCTAGGG
2F5_LC 5’2F5_LC_qPCR 5’ CTTCCCGCCATCTGATGAGC
3’2F5_LC_qPCR 5’ GAGGGCGTTATCCACCTTCC
List of primer sequences used for qRT-PCR assays with both genomic DNA
and cDNA.
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of the target and reference genes were not the same,
Pfaffl method [59] was chosen for the relative quantifi-
cation of qRT-PCR results.
Additional material
Additional file 1: Sterol profiling of P. pastoris cells by GC analysis.
Sterol composition profile of P. pastoris X-33 pGAPZaA Fab2F5 cells
treated with 0.6 μg ml-1 fluconazole and without treatment (control) was
determined by GC-MS. Chromatograms showing ergosterol depletion
and the appearance of two new unknown sterol peaks with a longer
retention time than ergosterol in fluconazole-treated cultures are
represented.
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